Mediwound Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Mediwound
MDWD Stock  USD 17.07  0.07  0.41%   
Mediwound's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mediwound's valuation are provided below:
Gross Profit
3.9 M
Profit Margin
(0.98)
Market Capitalization
218.2 M
Enterprise Value Revenue
8.019
Revenue
20.9 M
There are over one hundred nineteen available fundamental ratios for Mediwound, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of Mediwound's last-minute performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road.

Mediwound Total Revenue

13.84 Million

Check Mediwound financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mediwound's main balance sheet or income statement drivers, such as Depreciation And Amortization of 869.2 K, Interest Expense of 436.1 K or Selling General Administrative of 11.7 M, as well as many indicators such as Price To Sales Ratio of 9.58, Dividend Yield of 0.0 or PTB Ratio of 6.09. Mediwound financial statements analysis is a perfect complement when working with Mediwound Valuation or Volatility modules.
  
Build AI portfolio with Mediwound Stock
Check out the analysis of Mediwound Correlation against competitors.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

Mediwound Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding12 M11.5 M5.1 M
Slightly volatile
Total Assets47.4 M84.5 M43.7 M
Slightly volatile
Short and Long Term Debt Total4.1 M8 M5.1 M
Pretty Stable
Other Current Liabilities26.6 M25.3 M6.8 M
Slightly volatile
Total Current Liabilities32 M30.5 M10.5 M
Slightly volatile
Other Liabilities15.9 M23.6 M19 M
Slightly volatile
Property Plant And Equipment Net25.1 M23.9 M6.7 M
Slightly volatile
Accounts Payable3.2 M4.7 M2.8 M
Slightly volatile
Cash14.6 M8.2 M15.4 M
Pretty Stable
Non Current Assets Total25.8 M24.5 M11.1 M
Pretty Stable
Other Assets311.2 K327.6 K3 M
Slightly volatile
Cash And Short Term Investments33.1 M49.6 M27.9 M
Slightly volatile
Net Receivables4.4 M6.7 M3.9 M
Slightly volatile
Common Stock Total Equity61 K86.2 K56.7 K
Slightly volatile
Liabilities And Stockholders Equity47.4 M84.5 M43.7 M
Slightly volatile
Non Current Liabilities Total16.3 M14.2 M18.1 M
Very volatile
Inventory1.8 M3.1 M1.6 M
Slightly volatile
Other Current Assets533.4 K412.2 K594.9 K
Very volatile
Other Stockholder Equity147.1 M271.4 M132.5 M
Slightly volatile
Total Liabilities32.2 M48.7 M28.3 M
Slightly volatile
Property Plant And Equipment Gross34.7 M33 M8.7 M
Slightly volatile
Total Current Assets39.5 M60 M33.7 M
Slightly volatile
Short Term Debt357.4 K376.2 K2.2 M
Slightly volatile
Intangible Assets84.6 K89.1 K1.3 M
Slightly volatile
Common Stock259.6 K247.2 K96.5 K
Slightly volatile
Property Plant Equipment2.6 M4.1 M2.5 M
Slightly volatile
Long Term Debt7.8 M8.5 M7.3 M
Slightly volatile
Deferred Long Term Liabilities811.4 K889.2 K986.2 K
Slightly volatile
Short and Long Term Debt2.2 M2 M2.4 M
Slightly volatile
Current Deferred Revenue10.3 K10.8 K139.5 K
Very volatile
Non Current Liabilities Other10.8 M7.3 M15.7 M
Slightly volatile
Capital Surpluse153.8 M162 M141.9 M
Slightly volatile
Net Working Capital21 M23.1 M29.8 M
Slightly volatile
Capital Stock132.3 K247.2 K107.2 K
Slightly volatile
Long Term Debt Total1.6 M1.8 M2 M
Slightly volatile
Capital Lease Obligations7.9 M7.5 M3.1 M
Slightly volatile

Mediwound Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization869.2 K1.7 M813.7 K
Slightly volatile
Interest Expense436.1 K504.9 K539.1 K
Slightly volatile
Selling General Administrative11.7 M11.2 M5.6 M
Slightly volatile
Other Operating Expenses24.3 M45.5 M22.6 M
Slightly volatile
Research Development6.5 M9.5 M6 M
Slightly volatile
Total Operating Expenses16.2 M24.3 M14.8 M
Slightly volatile
Cost Of Revenue22.3 M21.2 M8.7 M
Slightly volatile
Selling And Marketing Expenses3.6 M2.9 M3.9 M
Pretty Stable
Interest Income2.5 M2.4 M1.1 M
Slightly volatile
Reconciled Depreciation1.2 M1.7 M910.4 K
Slightly volatile

Mediwound Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2 M3.6 M1.9 M
Slightly volatile
Begin Period Cash Flow18.4 M13.6 M15.9 M
Slightly volatile
Depreciation869.2 K1.7 M813.7 K
Slightly volatile
Capital Expenditures7.6 M7.2 M2.1 M
Slightly volatile
End Period Cash Flow19 M10.5 M16.1 M
Pretty Stable
Sale Purchase Of Stock17.7 M20.4 M20.9 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio9.5810.08179
Slightly volatile
Days Sales Outstanding1151211.1 K
Slightly volatile
Stock Based Compensation To Revenue0.170.185.9549
Slightly volatile
Capex To Depreciation4.03.812.1334
Pretty Stable
EV To Sales9.469.96144
Slightly volatile
Inventory Turnover3.986.174.2669
Slightly volatile
Days Of Inventory On Hand58.2161.27315
Slightly volatile
Payables Turnover4.254.052.3075
Slightly volatile
Research And Ddevelopement To Revenue0.450.477.3008
Slightly volatile
Capex To Revenue0.40.360.6402
Slightly volatile
Cash Per Share8.394.986.6351
Very volatile
Days Payables Outstanding88.5793.23410
Slightly volatile
Intangibles To Total Assets0.00150.00150.0469
Slightly volatile
Current Ratio2.152.264.6738
Pretty Stable
Receivables Turnover2.763.112.6104
Slightly volatile
Capex Per Share0.60.570.2941
Slightly volatile
Revenue Per Share2.31.832.1302
Slightly volatile
Interest Debt Per Share0.380.680.512
Pretty Stable
Debt To Assets0.05070.08490.0587
Slightly volatile
Graham Number17.5712.1812.9916
Slightly volatile
Operating Cycle174183907
Slightly volatile
Days Of Payables Outstanding88.5793.23410
Slightly volatile
Quick Ratio2.042.144.4679
Pretty Stable
Net Income Per E B T1.31.151.2017
Pretty Stable
Cash Ratio0.380.42.3949
Pretty Stable
Days Of Inventory Outstanding58.2161.27315
Slightly volatile
Days Of Sales Outstanding1151211.1 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.91.311.1366
Pretty Stable
Fixed Asset Turnover0.830.882.0565
Slightly volatile
Debt Ratio0.05070.08490.0587
Slightly volatile
Price Sales Ratio9.5810.08179
Slightly volatile
Asset Turnover0.290.250.267
Slightly volatile

Mediwound Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap80.1 M90.1 M98.3 M
Slightly volatile
Enterprise Value57 M64.1 M70 M
Slightly volatile

Mediwound Fundamental Market Drivers

Mediwound Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
4th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Mediwound Financial Statements

Mediwound stakeholders use historical fundamental indicators, such as Mediwound's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mediwound investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mediwound's assets and liabilities are reflected in the revenues and expenses on Mediwound's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mediwound. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue10.8 K10.3 K
Cost Of Revenue21.2 M22.3 M
Total Revenue23.3 M13.8 M
Stock Based Compensation To Revenue 0.18  0.17 
Research And Ddevelopement To Revenue 0.47  0.45 
Capex To Revenue 0.36  0.40 
Revenue Per Share 1.83  2.30 
Ebit Per Revenue(0.86)(0.91)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:
How To Invest In Mediwound
Details
Is Mediwound Stock a good investment?
Details
What is Mediwound's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Mediwound Correlation against competitors.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.84)
Revenue Per Share
1.927
Quarterly Revenue Growth
0.247
Return On Assets
(0.17)
Return On Equity
(0.49)
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY